Medicis Undeterred By Inamed’s Breast Implant Panel Woes
This article was originally published in The Gray Sheet
Executive Summary
Medicis has no immediate plans to revisit the financial details of its pending acquisition of Inamed, despite last week's negative FDA panel decision on the latter company's silicone breast implants